Back to Search Start Over

THERE IS NO WAY TO IDENTIFY PATIENTS WHO WILL HARBOR PT2A PROSTATE CANCER AT RADICAL PROSTATECTOMY. IMPLICATIONS FOR FOCAL THERAPIES

Tools

Authors Abstract Subjects Details